Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Gross Profit: 2012-2024

Historic Gross Profit for OptimizeRx (OPRX) over the last 13 years, with FY2024 value amounting to $59.4 million.

  • OptimizeRx's Gross Profit rose 3025.95% to $17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.5 million, marking a year-over-year increase of 2957.1%. This contributed to the annual value of $59.4 million for FY2024, which is 3841.03% up from last year.
  • As of FY2024, OptimizeRx's Gross Profit stood at $59.4 million, which was up 3841.03% from $42.9 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Gross Profit registered a high of $59.4 million during FY2024, and its lowest value of $24.1 million during FY2020.
  • Over the past 5 years, OptimizeRx's median Gross Profit value was $39.0 million (recorded in 2022), while the average stood at $40.2 million.
  • As far as peak fluctuations go, OptimizeRx's Gross Profit skyrocketed by 5612.75% in 2020, and later surged by 934.0% in 2022.
  • OptimizeRx's Gross Profit (Annual) stood at $24.1 million in 2020, then skyrocketed by 47.84% to $35.6 million in 2021, then rose by 9.34% to $39.0 million in 2022, then rose by 10.09% to $42.9 million in 2023, then surged by 38.41% to $59.4 million in 2024.
  • Its Gross Profit was $59.4 million in FY2024, compared to $42.9 million in FY2023 and $39.0 million in FY2022.